S

Sam-A Pharm Co Ltd
KOSDAQ:009300

Watchlist Manager
Sam-A Pharm Co Ltd
KOSDAQ:009300
Watchlist
Price: 15 780 KRW 0.51% Market Closed
Market Cap: ₩100.5B

Net Margin

17.2%
Current
Declining
by 3.4%
vs 3-y average of 20.6%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
17.2%
=
Net Income
₩13.2B
/
Revenue
₩76.7B

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
17.2%
=
Net Income
₩13.2B
/
Revenue
₩76.7B

Peer Comparison

Country Company Market Cap Net
Margin
KR
Sam-A Pharm Co Ltd
KOSDAQ:009300
96.3B KRW
Loading...
US
Eli Lilly and Co
NYSE:LLY
954.9B USD
Loading...
US
Johnson & Johnson
NYSE:JNJ
546.2B USD
Loading...
CH
Roche Holding AG
SIX:ROG
268.4B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
209.9B GBP
Loading...
CH
Novartis AG
SIX:NOVN
219B CHF
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
US
Merck & Co Inc
NYSE:MRK
265.4B USD
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
147.6B USD
Loading...
FR
Sanofi SA
PAR:SAN
94.4B EUR
Loading...

Market Distribution

Higher than 91% of companies in Korea
Percentile
91th
Based on 2 632 companies
91th percentile
17.2%
Low
-168 471.3% — -2.9%
Typical Range
-2.9% — 5.8%
High
5.8% — 21 012.5%
Distribution Statistics
Korea
Min -168 471.3%
30th Percentile -2.9%
Median 1.9%
70th Percentile 5.8%
Max 21 012.5%

Sam-A Pharm Co Ltd
Glance View

Market Cap
100.5B KRW
Industry
Pharmaceuticals

Sam-A Pharm.Co., Ltd. engages in the manufacture and sale of pharmaceuticals. The company is headquartered in Wonju, Gangwon-Do. The company went IPO on 2000-07-19. Co., Ltd is a Korea-based company engaged in the manufacture and sale of pharmaceuticals. The firm's products include remedies for respiratory, antibiotics, dermatitis treatments, dyspeptic agents, cold remedies, antifebriles, antiphlogistics, analgesics, antihistamines, and remedies for the circulatory, gastrointestinal, urinary systems, cardiovascular and other general pharmaceuticals. The company also provides children nutrition products under the brand name of NOMA.

Intrinsic Value
13 929.81 KRW
Overvaluation 12%
Intrinsic Value
Price
S
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
17.2%
=
Net Income
₩13.2B
/
Revenue
₩76.7B
What is Sam-A Pharm Co Ltd's current Net Margin?

The current Net Margin for Sam-A Pharm Co Ltd is 17.2%, which is below its 3-year median of 20.6%.

How has Net Margin changed over time?

Over the last 3 years, Sam-A Pharm Co Ltd’s Net Margin has increased from 14.6% to 17.2%. During this period, it reached a low of 14.6% on Dec 31, 2022 and a high of 24.1% on Jun 30, 2024.

Back to Top